Fig. 2From: Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & IIKaplan–Meier survival curves for overall survival in control and treated groups which showed that the difference in survival rate between these two groups was statistically significant (P < 0.001)Back to article page